Crewe Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Crewe Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-360	Closed	-$19K	–	1342
2022 Q3	$19K	Hold	360	–	–	﹤0.01%	486
2022 Q2	$9K	Buy	+360	New	+$7.93K	﹤0.01%	644

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crewe Advisors's CCXI Position: Q4 2022 in Review

Crewe Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 360 shares — an estimated $19K sold.

Crewe Advisors first reported a position in CCXI in Q2 2022 and held it in 2 quarters. The position peaked at $19K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Crewe Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Crewe Advisors sold 360 ChemoCentryx, Inc. shares in Q4 2022, an estimated $19K.
Crewe Advisors first reported a position in ChemoCentryx, Inc. in Q2 2022 and held it in 2 quarters.
Crewe Advisors's ChemoCentryx, Inc. position peaked at $19K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Crewe Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.